Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL226838 (SB-505124) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
activin A receptor type 1B/Activin receptor type-1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5310] [GtoPdb: 1787] [UniProtKB: P36896] | ||||||||
ChEMBL | Inhibition of ALK4 (unknown origin) by radioisotopic assay | B | 7.15 | pIC50 | 70 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
ChEMBL | Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay | B | 6.18 | pIC50 | 668 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5228-5231 [PMID:26483198] |
ChEMBL | Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay | B | 6.23 | pIC50 | 594 | nM | IC50 | Bioorg Med Chem (2011) 19: 2633-2640 [PMID:21435890] |
ChEMBL | Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay | B | 6.23 | pIC50 | 594 | nM | IC50 | Eur J Med Chem (2012) 57: 74-84 [PMID:23047226] |
ChEMBL | Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay | B | 6.23 | pIC50 | 590 | nM | IC50 | Bioorg Med Chem (2014) 22: 2724-2732 [PMID:24704197] |
ChEMBL | Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay | B | 6.23 | pIC50 | 590 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
receptor interacting serine/threonine kinase 2/Serine/threonine-protein kinase RIPK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5014] [GtoPdb: 2190] [UniProtKB: O43353] | ||||||||
ChEMBL | Inhibition of RIPK2 (unknown origin) by radioisotopic assay | B | 6.16 | pIC50 | 685 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
transforming growth factor beta receptor 1 in Human [GtoPdb: 1788] [UniProtKB: P36897] | ||||||||
GtoPdb | Assay used purified human TGFβR1 kinase domain produced in Sf9 insect cells. | - | 7.27 | pIC50 | 54 | nM | IC50 | Eur J Med Chem (2011) 46: 3917-25 [PMID:21696866] |
transforming growth factor beta receptor 1/TGF-beta receptor type-1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2021750] [GtoPdb: 1788] [UniProtKB: Q64729] | ||||||||
ChEMBL | Inhibition of ALK5 in mouse 4T1 cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay | B | 7.12 | pIC50 | 76.6 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
transforming growth factor beta receptor 1/TGF-beta receptor type I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4439] [GtoPdb: 1788] [UniProtKB: P36897] | ||||||||
ChEMBL | Antagonistic activity at TGFBR1 | F | 1.33 | pIC50 | -1.33 | - | logIC50 | Bioorg Med Chem Lett (2010) 20: 1918-1923 [PMID:20176484] |
ChEMBL | Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells | B | 6.77 | pIC50 | 169 | nM | IC50 | Bioorg Med Chem (2010) 18: 4459-4467 [PMID:20472445] |
ChEMBL | Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay | B | 7.26 | pIC50 | 54.4 | nM | IC50 | Eur J Med Chem (2012) 57: 74-84 [PMID:23047226] |
ChEMBL | Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay | B | 7.27 | pIC50 | 54 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
ChEMBL | Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells | B | 7.27 | pIC50 | 54 | nM | IC50 | Bioorg Med Chem (2011) 19: 2633-2640 [PMID:21435890] |
ChEMBL | Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay | B | 7.27 | pIC50 | 54 | nM | IC50 | Bioorg Med Chem (2014) 22: 2724-2732 [PMID:24704197] |
GtoPdb | Assay used purified human TGFβR1 kinase domain produced in Sf9 insect cells. | - | 7.27 | pIC50 | 54 | nM | IC50 | Eur J Med Chem (2011) 46: 3917-25 [PMID:21696866] |
ChEMBL | Inhibition of GST-tagged ALK5 kinase domain (unknown origin) using GST-tagged SMAD3 as substrate in presence of [33P] gammaATP by liquid scintillation counter method | B | 7.33 | pIC50 | 47 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 2070-2075 [PMID:31303386] |
ChEMBL | Inhibition of ALK5 assessed as inhibition of immobilized Smad3 phosphorylation | B | 7.33 | pIC50 | 47 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4868-4872 [PMID:19616940] |
ChEMBL | Inhibition of ALK5 in human HaCaT cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay | B | 7.36 | pIC50 | 43.8 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
ChEMBL | Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay | B | 7.46 | pIC50 | 34.9 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5228-5231 [PMID:26483198] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibition of VEGFR2 (unknown origin) by radioisotopic assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2014) 57: 4213-4238 [PMID:24786585] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]